Cargando…

The incidence of feline injection site sarcomas in the United Kingdom

BACKGROUND: Feline injection site sarcomas (FISS) are aggressive neoplasms that have been associated with vaccination. In North America the incidence estimates have varied from 1 case of FISS per 1,000-10,000 cats vaccinated. The aim of this study was to estimate the incidence of FISS in the United...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Rachel S, Pfeiffer, Dirk U, Adams, Vicki J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608079/
https://www.ncbi.nlm.nih.gov/pubmed/23339769
http://dx.doi.org/10.1186/1746-6148-9-17
_version_ 1782264185757892608
author Dean, Rachel S
Pfeiffer, Dirk U
Adams, Vicki J
author_facet Dean, Rachel S
Pfeiffer, Dirk U
Adams, Vicki J
author_sort Dean, Rachel S
collection PubMed
description BACKGROUND: Feline injection site sarcomas (FISS) are aggressive neoplasms that have been associated with vaccination. In North America the incidence estimates have varied from 1 case of FISS per 1,000-10,000 cats vaccinated. The aim of this study was to estimate the incidence of FISS in the United Kingdom (UK) in 2007. The ratio of FISS to vaccines sold in the UK was also estimated. Fourteen FISS were diagnosed by a convenience sample of 34 small animal veterinary practices in the United Kingdom in 2007 and were used as the numerator for the incidence estimates. Denominator data was obtained from the computer systems of each practice. Considering that a single cause relationship with vaccination is not proven, three different denominators (number of cats registered, the number of cat consultations undertaken and the number of vaccination visits for cats at the practices) were used to express the potential variation in risk. RESULTS: The incidence risk of FISS per year was estimated to be 1/16,000 -50,000 cats registered by practices, 1/10,000-20,000 cat consultations and 1/5,000-12,500 vaccination visits. CONCLUSION: When interpreting these findings, it needs to be taken into consideration that this sample of practices and their cats may not be representative of veterinary practices and cats at risk of FISS in the UK. However it can still be concluded with reasonable certainty that the incidence of FISS in the UK is very low.
format Online
Article
Text
id pubmed-3608079
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36080792013-04-01 The incidence of feline injection site sarcomas in the United Kingdom Dean, Rachel S Pfeiffer, Dirk U Adams, Vicki J BMC Vet Res Research Article BACKGROUND: Feline injection site sarcomas (FISS) are aggressive neoplasms that have been associated with vaccination. In North America the incidence estimates have varied from 1 case of FISS per 1,000-10,000 cats vaccinated. The aim of this study was to estimate the incidence of FISS in the United Kingdom (UK) in 2007. The ratio of FISS to vaccines sold in the UK was also estimated. Fourteen FISS were diagnosed by a convenience sample of 34 small animal veterinary practices in the United Kingdom in 2007 and were used as the numerator for the incidence estimates. Denominator data was obtained from the computer systems of each practice. Considering that a single cause relationship with vaccination is not proven, three different denominators (number of cats registered, the number of cat consultations undertaken and the number of vaccination visits for cats at the practices) were used to express the potential variation in risk. RESULTS: The incidence risk of FISS per year was estimated to be 1/16,000 -50,000 cats registered by practices, 1/10,000-20,000 cat consultations and 1/5,000-12,500 vaccination visits. CONCLUSION: When interpreting these findings, it needs to be taken into consideration that this sample of practices and their cats may not be representative of veterinary practices and cats at risk of FISS in the UK. However it can still be concluded with reasonable certainty that the incidence of FISS in the UK is very low. BioMed Central 2013-01-22 /pmc/articles/PMC3608079/ /pubmed/23339769 http://dx.doi.org/10.1186/1746-6148-9-17 Text en Copyright ©2013 Dean et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dean, Rachel S
Pfeiffer, Dirk U
Adams, Vicki J
The incidence of feline injection site sarcomas in the United Kingdom
title The incidence of feline injection site sarcomas in the United Kingdom
title_full The incidence of feline injection site sarcomas in the United Kingdom
title_fullStr The incidence of feline injection site sarcomas in the United Kingdom
title_full_unstemmed The incidence of feline injection site sarcomas in the United Kingdom
title_short The incidence of feline injection site sarcomas in the United Kingdom
title_sort incidence of feline injection site sarcomas in the united kingdom
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608079/
https://www.ncbi.nlm.nih.gov/pubmed/23339769
http://dx.doi.org/10.1186/1746-6148-9-17
work_keys_str_mv AT deanrachels theincidenceoffelineinjectionsitesarcomasintheunitedkingdom
AT pfeifferdirku theincidenceoffelineinjectionsitesarcomasintheunitedkingdom
AT adamsvickij theincidenceoffelineinjectionsitesarcomasintheunitedkingdom
AT deanrachels incidenceoffelineinjectionsitesarcomasintheunitedkingdom
AT pfeifferdirku incidenceoffelineinjectionsitesarcomasintheunitedkingdom
AT adamsvickij incidenceoffelineinjectionsitesarcomasintheunitedkingdom